New trends in treating bipolar disorder

Melvin McInnis, M.D., principal investigator of the Prechter Bipolar Research Fund, and an associate director of the Depression Center, was quoted in a dailyRX article on advances in medications used to treat bipolar disorder. "We've got a new generation of medication with fewer side effects, but the long-term challenges remain pretty high," McInnis said. Read more…